S 5510 · 118th Congress
Open Payments Expansion Act
This bill requires drug and medical device manufacturers to publicly report any money they give to patient advocacy organizations. Starting in March 2026, and then every year after that, these companies must disclose the name of each patient advocacy group they funded and how much money they gave them. This applies…
- Sponsor
- Grassley, Chuck (R-IA)
- Introduced
- 2024-12-12
- Policy area
- Social Welfare
- Latest action
- Read twice and referred to the Committee on Finance.
Digging through Congress... 🔍